Therapeutic strategy for severe COVID-19 pneumonia from clinical experience

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first identified in December 2019 in Wuhan, China, and has resulted in global pandemic. There is currently no effective therapeutic strategy for the management...

Full description

Bibliographic Details
Main Authors: Fumihiro Ogawa, Hideaki Kato, Kento Nakajima, Tomoki Nakagawa, Reo Matsumura, Yasufumi Oi, Kazuya Sakai, Munehito Uchiyama, Yutaro Ohyama, Takeru Abe, Ichiro Takeuchi
Format: Article
Language:English
Published: SAGE Publishing 2020-09-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/2058739220961591